UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

PLoS pathogens, 2009-05, Vol.5 (5), p.e1000433-e1000433

2009

Link zum Volltext

Verfügbarkeit prüfen

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic

Drug discovery today, 2021-02, Vol.26 (2), p.593-603

2021

Link zum Volltext

Verfügbarkeit prüfen

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

Nature (London), 2012-02, Vol.482 (7383), p.89-93

2012

Link zum Volltext

Verfügbarkeit prüfen

Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

Journal of Virology, 2010-02, Vol.84 (3), p.1302-1313

2010

Link zum Volltext

Verfügbarkeit prüfen

Antibody-dependent enhancement and the risk of HIV infection

Current HIV research, 2013-07, Vol.11 (5), p.421

2013

Link zum Volltext

Verfügbarkeit prüfen

Association between vaccine preventable diseases in children and improved sanitation following a nationwide sanitation campaign in India: an ecological analysis

BMJ open, 2022-04, Vol.12 (4), p.e052937-e052937

2022

Link zum Volltext

Verfügbarkeit prüfen

Antibody-dependent cellular cytotoxicity in HIV infection

AIDS (London), 2018-11, Vol.32 (17), p.2439-2451

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevention and Treatment of Monkeypox

Drugs (New York, N.Y.), 2022-06, Vol.82 (9), p.957-963

2022

Link zum Volltext

Verfügbarkeit prüfen

Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis

PLoS pathogens, 2017-12, Vol.13 (12), p.e1006793-e1006793

2017

Link zum Volltext

Verfügbarkeit prüfen

Comment on the immunogenicity of the Noora vaccine against SARS‐CoV‐2

Journal of medical virology, 2023-05, Vol.95 (5), p.e28731-n/a

Forthal, Donald N.

2023

Link zum Volltext

Verfügbarkeit prüfen

Glycan modulation and sulfoengineering of anti–HIV-1 monoclonal antibody PG9 in plants

Proceedings of the National Academy of Sciences - PNAS, 2015-10, Vol.112 (41), p.12675-12680

2015

Link zum Volltext

Verfügbarkeit prüfen

Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

Nature medicine, 2010-10, Vol.16 (10), p.1117-1119

2010

Link zum Volltext

Verfügbarkeit prüfen

The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells

PLoS pathogens, 2013-11, Vol.9 (11), p.e1003776-e1003776

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmaco-Immunomodulatory Therapy in COVID-19

Drugs (New York, N.Y.), 2020-09, Vol.80 (13), p.1267-1292

2020

Link zum Volltext

Verfügbarkeit prüfen

Functions of Antibodies

Microbiology spectrum, 2014-08, Vol.2 (4), p.AID-0019-2014

2014

Link zum Volltext

Verfügbarkeit prüfen

Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features

Retrovirology, 2021-10, Vol.18 (1), p.35-35, Article 35

2021

Link zum Volltext

Verfügbarkeit prüfen

A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens

PloS one, 2015-05, Vol.10 (5), p.e0125581-e0125581

2015

Link zum Volltext

Verfügbarkeit prüfen

Protection Afforded by an HIV Vaccine Candidate in Macaques Depends on the Dose of SIVmac251 at Challenge Exposure

Journal of Virology, 2013-03, Vol.87 (6), p.3538-3548

2013

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study

PloS one, 2014-01, Vol.9 (1), p.e85371-e85371

2014

Link zum Volltext

Verfügbarkeit prüfen

HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and are Commonly Detected in Plasma from HIV-infected Humans

EBioMedicine, 2015-10, Vol.2 (10), p.1464-1477

2015

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing Polyclonal IgG Present during Acute Infection Prevents Rapid Disease Onset in Simian-Human Immunodeficiency Virus SHIVSF162P3-Infected Infant Rhesus Macaques

Journal of Virology, 2013-10, Vol.87 (19), p.10447-10459

2013

Link zum Volltext

Verfügbarkeit prüfen

Rhesus Macaque Polyclonal and Monoclonal Antibodies Inhibit Simian Immunodeficiency Virus in the Presence of Human or Autologous Rhesus Effector Cells

Journal of Virology, 2006-09, Vol.80 (18), p.9217-9225

2006

Link zum Volltext

Verfügbarkeit prüfen

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

PloS one, 2016-08, Vol.11 (8), p.e0160341-e0160341

2016

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 infection of endothelial cells, dependent on flow-induced ACE2 expression, drives hypercytokinemia in a vascularized microphysiological system

Frontiers in cardiovascular medicine, 2024, Vol.11, p.1360364-1360364

2024

Link zum Volltext

Verfügbarkeit prüfen

A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1

PloS one, 2013-08, Vol.8 (8), p.e72054-e72054

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(136)
Buchkapitel
(1)

Sprache

Englisch
(137)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(100)
Life Sciences & Biomedicine
(91)
Humans
(82)
Immunology
(54)
Virology
(45)
Animals
(42)
Infectious Diseases
(40)
Hiv
(39)
Human Immunodeficiency Virus
(39)
Biological And Medical Sciences
(36)
Microbiology
(34)
Female
(33)
Hiv-1 - Immunology
(33)
Male
(32)
Human Immunodeficiency Virus 1
(30)
Hiv Infections - Immunology
(29)
Macaca Mulatta
(29)
Medical Sciences
(26)
Hiv Antibodies - Immunology
(23)
Simian Immunodeficiency Virus - Immunology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

Antibody-dependent enhancement and the risk of HIV infection

Association between vaccine preventable diseases in children and improved sanitation following a nationwide sanitation campaign in India: an ecological analysis

Antibody-dependent cellular cytotoxicity in HIV infection

Prevention and Treatment of Monkeypox

Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis

Comment on the immunogenicity of the Noora vaccine against SARS‐CoV‐2

Glycan modulation and sulfoengineering of anti–HIV-1 monoclonal antibody PG9 in plants

Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells

Pharmaco-Immunomodulatory Therapy in COVID-19

Functions of Antibodies

Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features

A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens

Protection Afforded by an HIV Vaccine Candidate in Macaques Depends on the Dose of SIVmac251 at Challenge Exposure

HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study

HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and are Commonly Detected in Plasma from HIV-infected Humans

Neutralizing Polyclonal IgG Present during Acute Infection Prevents Rapid Disease Onset in Simian-Human Immunodeficiency Virus SHIVSF162P3-Infected Infant Rhesus Macaques

Rhesus Macaque Polyclonal and Monoclonal Antibodies Inhibit Simian Immunodeficiency Virus in the Presence of Human or Autologous Rhesus Effector Cells

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

SARS-CoV-2 infection of endothelial cells, dependent on flow-induced ACE2 expression, drives hypercytokinemia in a vascularized microphysiological system

A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1

Suchergebnisse filtern